MindMed Launches Study of Low-Dose LSD Effects on Sleep and Cognitive Measures

Mind Medicine (MindMed) announced that it has launched recruitment for a randomized placebo-controlled study evaluating the effects of daytime and evening administration of repeated low doses of LSD (the “LSD Study”).

Compound LSD
Visit article
Category Press Release
Published in Yahoo

Companies Featured

MindMed
MindMed is one of the largest companies in the psychedelics space and is developing various psychedelics for mental health disorders.